革新给予动物更多福利

诗华研发团队遍布全球不同区域,致力于开发创新性的药物分子和产品组合,以应对反刍动物的传染性疾病。
菜单
Collaboration in more than 46 countries.
You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
GLOBAL
CEVA Global
EMEA (REGIONAL)
Belgium
Bulgaria
Denmark
Egypt
France
Germany
Greece
Italy
Netherlands
Poland
Portugal
Russia
Spain
Sweden
Tunisia
Turkey
Ukraine
United Kingdom
ASIA PACIFIC
Asia Pacific (Regional)
CHINA
India
Indonesia
Japan
Kore
Malaysia
Philippines
Vietnam
Ceva 全球
Collaboration in more than 46 countries.
You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
GLOBAL
CEVA Global
EMEA (REGIONAL)
Belgium
Bulgaria
Denmark
Egypt
France
Germany
Greece
Italy
Netherlands
Poland
Portugal
Russia
Spain
Sweden
Tunisia
Turkey
Ukraine
United Kingdom
ASIA PACIFIC
Asia Pacific (Regional)
CHINA
India
Indonesia
Japan
Kore
Malaysia
Philippines
Vietnam
诗华研发团队遍布全球不同区域,致力于开发创新性的药物分子和产品组合,以应对反刍动物的传染性疾病。
诗华研发团队遍布全球不同区域,致力于开发创新性的药物分子和产品组合,以应对反刍动物的传染性疾病。